Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2. Bilateral abnormalities in neuropathic pain<br />
Thermal hypesthesias were observed also in most of the patients for CDT, WDT and<br />
TSL. For MDT there was predominantly a sensory loss observed indicating a mechanical<br />
hypesthesia. It was possible to detect hyperesthesia for VDT for one patient, but for the<br />
large majority VDT responses indicated hypesthesia.<br />
In 25% (n=20) of the patients a sensory gain for PHS was detected at the affected side.<br />
DMA was present in 26% of the patients, in 6% of very mild intensity, however, 20%<br />
of patients showed a clinical relevant increased response for DMA indicating a dynamic<br />
allodynia.<br />
3.3.3. <strong>Sensory</strong> changes at the patient’s contralateral side<br />
<strong>Sensory</strong> abnormalities at the contralateral side ranged from 1.2% (n=1) for CPT to<br />
29.6% (n=24) for PPT. With the exception of CPT, 95% Confidence Intervals confirmed<br />
that the prevalence differed significantly from zero (p